Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update
- 1 June 2024
- journal article
- research article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 67 (6) , 2161-2184
Abstract
Phage libraries are now amongst the most prominent approaches for the identification of high-affinity antibodies/peptides from billions of displayed phages in a specific library through the biopanning process. Due to its ability to discover potential therapeutic candidates that bind specifically to targets, phage display has gained considerable attention in targeted therapy. Using this approach, peptides with high-affinity and specificity can be identified for potential therapeutic or diagnostic use. Furthermore, phage libraries can be used to rapidly screen and identify novel antibodies to develop immunotherapeutics. The Food and Drug Administration (FDA) has approved several phage display-derived peptides and antibodies for the treatment of different diseases. In the current review, we provided a comprehensive insight into the role of phage display-derived peptides and antibodies in the treatment of different diseases including cancers, infectious diseases and neurological disorders. We also explored the applications of phage display in targeted drug delivery, gene therapy, and CAR T-cell. Graphical AbstractKeywords
Funding Information
- Drug Applied Research Center, Tabriz University of Medical Sciences (66554)
This publication has 235 references indexed in Scilit:
- Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapyInternational Journal of Cancer, 2001
- Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity AntibodiesJournal of Biological Chemistry, 1999
- Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural CytokineScience, 1997
- Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide libraryThe Journal of Immunology, 1996
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990
- Random Peptide Libraries: a Source of Specific Protein Binding MoleculesScience, 1990
- Searching for Peptide Ligands with an Epitope LibraryScience, 1990
- Antibody-selectable filamentous fd phage vectors: affinity purification of target genesGene, 1988
- Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion SurfaceScience, 1985